Access the full text.
Sign up today, get DeepDyve free for 14 days.
John Rosen, Alan Fleischman, Laurence Finberg, A. Hamstra, H. Deluca (1979)
Rickets with alopecia: an inborn error of vitamin D metabolism.The Journal of pediatrics, 94 5
Shigeharu Dokoh, C. Donaldson, M. Haussler (1984)
Influence of 1,25-dihydroxyvitamin D3 on cultured osteogenic sarcoma cells: correlation with the 1,25-dihydroxyvitamin D3 receptor.Cancer research, 44 5
W. Stumpf, M. Sar, F. Reid, Y. Tanaka, H. DeLuca (1979)
Target cells for 1,25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid.Science, 206 4423
A. Baker, Donald MCDONNELLt, M. HUGHESt, T. Crisp, D. MANGELSDORFt, M. Haussler, J. PIKEt, J. Shine, Bert O'MALLEYt (1988)
Cloning and expression of full-length cDNA encoding human vitamin D receptor.Proceedings of the National Academy of Sciences of the United States of America, 85 10
T. Ross, H. Darwish, H. DeLuca (1994)
Molecular biology of vitamin D action.Vitamins and hormones, 49
M. Holick, M. Garabédian, H. DeLuca (1972)
1,25-Dihydroxycholecalciferol: Metabolite of Vitamin D3 Active on Bone in Anephric RatsScience, 176
R. Kurokawa, J. Direnzo, M. Boehm, J. Sugarman, B. Gloss, M. Rosenfeld, R. Heyman, C. Glass (1994)
Regulation of retinoid signalling by receptor polarity and allosteric control of ligand bindingNature, 371
J. Burmester, Nobuyo Maeda, H. DeLuca (1988)
Isolation and expression of rat 1,25-dihydroxyvitamin D3 receptor cDNA.Proceedings of the National Academy of Sciences of the United States of America, 85 4
H. Morii, J. Lund, P. Neville, H. DeLuca (1967)
Biological activity of a vitamin D metaboliteArchives of Biochemistry and Biophysics, 120
M. Munder, I. Herzberg, C. Zierold, V. Moss, K. Hanson, M. Clagett-Dame, H. DeLuca (1995)
Identification of the porcine intestinal accessory factor that enables DNA sequence recognition by vitamin D receptor.Proceedings of the National Academy of Sciences of the United States of America, 92
E. Baur, C. Zechel, D. Heery, M. Heine, J. Garnier, V. Vivat, B. Douarin, H. Gronemeyer, P. Chambon, R. Losson (1996)
Differential ligand‐dependent interactions between the AF‐2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1.The EMBO Journal, 15
Shou-chuan Yang, C. Smith, H. DeLuca (1993)
1α,25-dihydroxyvitamin D3 a nd 19-nor-1α,25-dihydroxyvitamin 32 suppress immunoglobulin production and thymic lymphocyte proliferation in vivoBiochimica et Biophysica Acta, 1158
C. Kimmel-Jehan, F. Jehan, H. DeLuca (1997)
Salt concentration determines 1,25-dihydroxyvitamin D3 dependency of vitamin D receptor-retinoid X receptor--vitamin D-responsive element complex formation.Archives of biochemistry and biophysics, 341 1
M. Cantorna, C. Hayes, H. DeLuca (1996)
1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis.Proceedings of the National Academy of Sciences of the United States of America, 93 15
H. DeLuca (1974)
Vitamin D: the vitamin and the hormone.Federation proceedings, 33 11
J. Pike, S. Marion, C. Donaldson, M. Haussler (1983)
Serum and monoclonal antibodies against the chick intestinal receptor for 1,25-dihydroxyvitamin D3. Generation by a preparation enriched in a 64,000-dalton protein.The Journal of biological chemistry, 258 2
Kai-Shun Chen, Hector Deluca (1995)
Cloning of the human 1 alpha,25-dihydroxyvitamin D-3 24-hydroxylase gene promoter and identification of two vitamin D-responsive elements.Biochimica et biophysica acta, 1263 1
C. Zierold, H. Darwish, H. DeLuca (1995)
Two Vitamin D Response Elements Function in the Rat 1,25-Dihydroxyvitamin D 24-Hydroxylase Promoter (*)The Journal of Biological Chemistry, 270
Bryan Lemon, Leonard Freedman (1996)
Selective effects of ligands on vitamin D3 receptor- and retinoid X receptor-mediated gene activation in vivoMolecular and Cellular Biology, 16
R. Wiese, H. Goto, J. Prahl, S. Marx, Monique Thomas, A. Al-aqeel, H. DeLuca (1993)
Vitamin D-dependency rickets type II: truncated vitamin D receptor in three kindredsMolecular and Cellular Endocrinology, 90
F. Jehan, Hector Deluca (1997)
Cloning and characterization of the mouse vitamin D receptor promoter.Proceedings of the National Academy of Sciences of the United States of America, 94 19
R. Brommage, H. DeLuca (1985)
Evidence that 1,25-dihydroxyvitamin D3 is the physiologically active metabolite of vitamin D3.Endocrine reviews, 6 4
R. Simpson, A. Hamstra, N. Kendrick, H. DeLuca (1983)
Purification of the receptor for 1 alpha,25-dihydroxyvitamin D3 from chicken intestine.Biochemistry, 22 10
E. Ohshima, H. Sai, S. Takatsuto, N. Ikekawa, Y. Kobayashi, Y. Tanaka, H. DeLuca (1984)
Synthesis and biological activity of 1 alpha-fluoro-25-hydroxyvitamin D3.Chemical & pharmaceutical bulletin, 32 9
Leonard Freedman, Víctor Arce, R. Fernandez (1994)
DNA sequences that act as high affinity targets for the vitamin D3 receptor in the absence of the retinoid X receptor.Molecular endocrinology, 8 3
Zhongjian Lu, K. Hanson, H. DeLuca (1997)
Cloning and origin of the two forms of chicken vitamin D receptor.Archives of biochemistry and biophysics, 339 1
I. Nemere (1995)
Nongenomic effects of 1,25-dihydroxyvitamin D3: potential relation of a plasmalemmal receptor to the acute enhancement of intestinal calcium transport in chick.The Journal of nutrition, 125 6 Suppl
Shouli Yang, C. Smith, J. Prahl, Xiaolong Luo, H. DeLuca (1993)
Vitamin D deficiency suppresses cell-mediated immunity in vivo.Archives of biochemistry and biophysics, 303 1
K. Perlman, J. Prahl, C. Smith, A. Kutner, H. DeLuca (1994)
26,27-Dihomo-1 alpha-hydroxy- and 26,27-dihomo-24-epi-1 alpha,25-dihydroxyvitamin D2 analogs that differ markedly in biological activity in vivo.The Journal of biological chemistry, 269 39
H. Deluca (1993)
Vitamin D: 1993Nutrition Today, 28
J. Burmester, R. Wiese, N. Maeda, H. DeLuca (1988)
Structure and regulation of the rat 1,25-dihydroxyvitamin D3 receptor.Proceedings of the National Academy of Sciences of the United States of America, 85 24
K. Umesono, K. Murakami, C. Thompson, R. Evans (1991)
Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptorsCell, 65
S. Manolagas, F. Hustmyer, Xiao-peng Yu (1989)
1,25-Dihydroxyvitamin D3 and the Immune SystemProceedings of the Society for Experimental Biology and Medicine, 191
I. Boyle, L. Miravet, R. Gray, M. Holick, H. DeLuca (1972)
The response of intestinal calcium transport to 25-hydroxy and 1,25-dihydroxy vitamin D in nephrectomized rats.Endocrinology, 90 3
H. DeLuca (1992)
New Concepts of Vitamin D Functions aAnnals of the New York Academy of Sciences, 669
J. Pike (1991)
Vitamin D3 receptors: structure and function in transcription.Annual review of nutrition, 11
D. McDonnell, J. Pike, B. O'malley (1988)
The vitamin D receptor: a primitive steroid receptor related to thyroid hormone receptor.Journal of steroid biochemistry, 30 1-6
J. Lund, H. DeLuca (1966)
Biologically active metabolite of vitamin D3 from bone, liver, and blood serum.Journal of lipid research, 7 6
T. Yoshizawa, Y. Handa, Y. Uematsu, S. Takeda, K. Sekine, Yuko Yoshihara, Toru Kawakami, Kouki Arioka, Hiroshi Sato, Y. Uchiyama, S. Masushige, A. Fukamizu, Toshio Matsumoto, S. Kato (1997)
Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaningNature Genetics, 16
H. Masuyama, S. Jefcoat, P. MacDonald (1997)
The N-terminal domain of transcription factor IIB is required for direct interaction with the vitamin D receptor and participates in vitamin D-mediated transcription.Molecular endocrinology, 11 2
M. Dame, E. Pierce, J. Prahl, C. Hayes, H. DeLuca (1986)
Monoclonal antibodies to the porcine intestinal receptor for 1,25-dihydroxyvitamin D3: interaction with distinct receptor domains.Biochemistry, 25 16
H. DeLuca, H. Schnoes (1983)
Vitamin D: recent advances.Annual review of biochemistry, 52
M. Brooks, Norman Bell, Leon Love, P. Stern, Emilio Orfei, Sherry Queener, Allen Hamstra, H. DeLuca (1978)
Vitamin-D-dependent rickets type II. Resistance of target organs to 1,25-dihydroxyvitamin D.The New England journal of medicine, 298 18
H. DeLuca (1980)
THE CONTROL OF CALCIUM AND PHOSPHORUS METABOLISM BY THE VITAMIN D ENDOCRINE SYSTEM*Annals of the New York Academy of Sciences, 355
H. DeLuca (1988)
The vitamin D story: a collaborative effort of basic science and clinical medicine 1The FASEB Journal, 2
I. Nemere, Y. Yoshimoto, A. Norman (1984)
Calcium transport in perfused duodena from normal chicks: enhancement within fourteen minutes of exposure to 1,25-dihydroxyvitamin D3.Endocrinology, 115 4
J. Eisman, T. Martin, I. Macintyre (1980)
1,25-DIHYDROXYVITAMIN D3 RECEPTORS IN CANCERThe Lancet, 315
Jorge Blanco, I-Ming Wang, Su-Chen Tsai, M. Tsai, B. O’Malley, P. Jurutka, M. Haussler, Keiko Ozato (1995)
Transcription factor TFIIB and the vitamin D receptor cooperatively activate ligand-dependent transcription.Proceedings of the National Academy of Sciences of the United States of America, 92
E. Abe, C. Miyaura, H. Sakagami, M. Takeda, K. Konno, T. Yamazaki, S. Yoshiki, T. Suda (1981)
Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3.Proceedings of the National Academy of Sciences of the United States of America, 78 8
J. Pike, M. Haussler (1979)
Purification of chicken intestinal receptor for 1,25-dihydroxyvitamin D.Proceedings of the National Academy of Sciences of the United States of America, 76 11
M. Hughes, P. Malloy, D. Kieback, D. McDonnell, D. Feldman, J. Pike, B. O’Malley (1989)
Human vitamin D receptor mutations: identification of molecular defects in hypocalcemic vitamin D resistant rickets.Advances in experimental medicine and biology, 255
S. Kliewer, K. Umesono, D. Mangelsdorf, R. Evans (1992)
Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signallingNature, 355
P. Malloy, Zeev Hochberg, D. Tiosano, J. Pike, Mark Hughes, David Feldman (1990)
The molecular basis of hereditary 1,25-dihydroxyvitamin D3 resistant rickets in seven related families.The Journal of clinical investigation, 86 6
D. Fraser, S. Kooh, H. Kind, M. Holick, Yoko Tanaka, H. DeLuca (1973)
Pathogenesis of Hereditary Vitamin-D-Dependent RicketsThe New England Journal of Medicine, 289
M. Holick (1989)
1,25-Dihydroxyvitamin D3 and the Skin: A Unique Application for the Treatment of PsoriasisProceedings of the Society for Experimental Biology and Medicine, 191
H. Tanaka, E. Abe, C. Miyaura, T. Kuribayashi, K. Konno, Y. Nishii, T. Suda (1982)
1 alpha,25-Dihydroxycholecalciferol and a human myeloid leukaemia cell line (HL-60).The Biochemical journal, 204 3
The vitamin D hormone, 1,25-dihydroxyvitamin D3, functions by way of a nuclear receptor (vitamin D receptor [VDR]) in a manner analogous to the other members of the steroid-thyroid hormone superfamily. Although the vitamin D receptor has been cloned, its three-dimensional structure remains unknown. The VDR binds to the direct repeat response elements called DR-3 in the promoter region of target genes to stimulate or suppress transcription of those genes encoding for proteins that carry out a wide variety of functions. The binding of the VDR to a DR-3 requires the presence of its ligand and a companion protein, namely the RXR group of retinoid receptors. The RXR binds to the 5′ arm of the response element while the VDR binds to the 3′ arm. In addition, the transcription factor TFIIB has been shown to bind VDR but there is currently no evidence that a compressor or co-activator of VDR is also involved. Phosphorylation of VDR in the transcription complex occurs as does bending of the DNA prior to the initiation or suppression of transcription.As VDR has been detected in cells not previously thought to be target organs, scientists continue to discover new functions of vitamin D. Among these new functions are those noted in the immune system. Experiments in mice have illustrated that the autoimmune diseases of multiple sclerosis and rheumatoid arthritis can be successfully treated with the vitamin D hormone and its analogs. New experiments illustrating the use of the vitamin D hormone and its analogs in suppressing transplant rejection indicate that these compounds may be superior to cyclosporin and may not have the side effects attributed to the cyclosporin immunosuppression therapies.
Nutrition Reviews – Oxford University Press
Published: Feb 1, 1998
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.